8-K: Lixte Biotechnology Completes $6.5M Loan for NOMAD Acquisition

Lixte Biotechnology Holdings, Inc. has provided a $6.5 million loan to NOMAD Transportable Power Systems, Inc. ahead of their acquisition, expected to close around July 1, 2026.

Summary

• Lixte Biotechnology Holdings, Inc. has issued a $6.5 million secured promissory note to NOMAD Transportable Power Systems, Inc. (NOMAD).
• This loan is intended to fund the procurement of long-lead components for NOMAD's active order pipeline and support working capital needs as NOMAD scales manufacturing.
• The acquisition of NOMAD by Lixte is expected to close on or about July 1, 2026, subject to customary closing conditions.
• Upon closing, the combined company will be renamed NOMAD Power Solutions, Inc. and will trade under a new ticker symbol on the Nasdaq Stock Market.
• The loan proceeds will also be used to repay NOMAD's outstanding obligations under a prior loan agreement.
• The Note matures 30 days from issuance, with automatic 30-day extensions possible as long as the Merger Agreement remains in effect.
• The outstanding principal of the Note will be offset against amounts deliverable to NOMAD upon closing of the merger.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development, indicating strong commitment to the acquisition and proactive funding to support NOMAD's growth, aligning with significant industry demand.

Positives

• Lixte is providing crucial pre-closing capital to NOMAD to accelerate commercial momentum and ensure uninterrupted production.
• The $6.5 million loan will help NOMAD procure necessary components and support working capital as it scales manufacturing to meet demand.
• The acquisition is on track to close around July 1, 2026, indicating progress in the strategic move.
• The combined entity will be rebranded as NOMAD Power Solutions, Inc., reflecting a focused strategy on power solutions.
• NOMAD's technology is highlighted as purpose-built for the data center era, addressing critical power needs for AI compute and high-density infrastructure.
• NOMAD's platform is described as utility-grade, mobile, and validated for deployment by utilities and industrial operators.

Negatives

• The loan is secured by a first-priority security interest in substantially all of NOMAD's assets, indicating potential risk for NOMAD if the merger fails.
• The loan matures in 30 days, though extensions are possible, creating a short-term financial obligation.
• The filing details potential termination clauses for the merger agreement that could trigger immediate repayment of the note, depending on which party is in breach.

Risks

• The acquisition is subject to customary closing conditions and required approvals, which may not be met.
• If the Merger Agreement is terminated due to a breach by Lixte, the Note will be repayable within six months.
• If the Merger Agreement is terminated due to a breach by NOMAD, the Note will be due and payable within three days.
• The forward-looking statements are subject to risks and uncertainties that could cause actual results to differ significantly from anticipated outcomes.

Future Outlook

The acquisition of NOMAD is expected to close on or about July 1, 2026. Following the closing, the combined company will be renamed NOMAD Power Solutions, Inc. and will trade under a new ticker symbol on the Nasdaq Stock Market. The company anticipates NOMAD's technology will be crucial for addressing power availability constraints in the data center market driven by AI.

Management Comments

• "Putting capital to work now, ahead of closing, reflects our conviction in NOMADs platform and attempting to fulfill the demand we are seeing," said Geordan Pursglove, Chief Executive Officer of LIXTE Biotechnology Holdings, Inc.
• "This loan allows NOMAD to keep pace with its order book and continue scaling without delay as we move toward completing the transaction."
• "NOMAD has built over the last six years a mobile utility-grade BESS platform engineered to the standards that utilities and hyperscale operators require," said John Travaglini, Chief Executive Officer of NOMAD Transportable Power Systems.
• "The acceleration in demand from AI infrastructure and data center customers confirms that deployable, utility-grade storage is becoming an essential layer of the modern grid."

Industry Context

StockSavvy.ai notes that this transaction signals a strategic pivot for Lixte Biotechnology Holdings, Inc., moving from its pharmaceutical focus to the rapidly growing energy storage and data center infrastructure market through the acquisition of NOMAD. The increasing demand for power solutions driven by AI and data center expansion is a significant industry trend.

Stakeholder Impact

• Shareholders: The acquisition and rebranding represent a significant strategic shift, potentially impacting future company valuation and market position.
• Creditors: NOMAD's existing obligations under the Loan and Security Agreement are being repaid with proceeds from the new loan.
• Suppliers: NOMAD's ability to scale manufacturing may lead to increased orders for components and raw materials.

Next Steps

• Closing of the acquisition of NOMAD Transportable Power Systems, Inc. on or about July 1, 2026.
• Renaming the combined company to NOMAD Power Solutions, Inc.
• Commencing trading under a new ticker symbol on the Nasdaq Stock Market.
• Utilizing the loan proceeds to fund NOMAD's order backlog and working capital needs.

Key Dates

Recommendation

The filing details a significant strategic shift and a substantial pre-closing loan, but the core business of Lixte Biotechnology (pharmaceuticals) is being overshadowed by the acquisition of an energy storage company. Investors need to assess the viability and integration success of NOMAD and the future strategy of the combined entity before making a definitive investment decision.

Keywords

NOMAD Transportable Power Systems, Lixte Biotechnology Holdings, Merger Agreement, Secured Promissory Note, Battery Energy Storage Systems, Data Center Power, Acquisition, Working Capital